SAN DIEGO, April 22, 2025--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, Image and Likeness program ...

The 15-day G7 CGM in use. [Image courtesy of Dexcom] Dexcom (Nadsaq:DXCM) announced today that the FDA cleared its G7 15-day continuous glucose monitoring (CGM) system. The clearance covers people ...

Now the longest lasting and most accurate CGM system, Dexcom G7 15 Day gives users the knowledge to better control diabetes. Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is ...

This includes the Japanese Red Maple Bonsai, priced at $59.99. Additionally, the LEGO Art collection will add the Art Fauna Collection Tiger Building set to the lineup, priced at $64.99. Upon ...

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch Dexcom G7 15-Day CGM approved by FDA for adults with diabetes; U.S. launch set for late 2025 with extended ...

Dexcom pushed back on claims in a Food and Drug Administration warning letter that the company made unauthorized changes to its glucose sensors. Company spokesperson Nadia Conard wrote in an email ...

Dexcom’s first-of-its-kind NIL program is accepting nominations for passionate and inspiring college athletes with diabetes for its 2025 roster now through May 23. Selected athletes will be ...

She is also a Certified Stress Management Coach. The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes.

That may be one reason why the ability to monitor glucose levels on an Apple Watch became a favorite feature among Dexcom G5 users after its debut in 2015, and since then, many more users have ...